Skip to main content
OpenTrials
Completed

NCT Number: NCT03844282

Research Evaluating Sports ConcUssion Events - Rapid Assessment of Concussion and Evidence for Return

RESCUE-RACER is jointly sponsored by the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust.

The RESCUE-RACER programme evaluates motorsports competitors at baseline (CArBON) and post-injury (CARS). The CArBON study (Competitor Assessment at Baseline; Ocular, Neuroscientific) collects a battery of neuroscientific data in a baseline assessment. The CARS study (Concussion Assessment and Return to motorSport), repeats the CArBON battery throughout the recovery period in competitors who sustain a potentially concussive event during motorsport.

The primary outcome of the RESCUE-RACER programme is to establish the natural history of concussive symptoms and signs in motorsport competitors using a comprehensive neuroscientific battery. The standard clinical assessment of concussive symptoms will be correlated with objective clinical scoring, in addition to neurocognitive and neuropsychological assessments. Advanced brain imaging with MRI will be used to further characterize head injuries in motorsport. Finally, salivary biomarkers will be collected to monitor the measurable biological effects of a potentially concussive event immediately following injury and through recuperation in the recovery period.

The secondary outcome is investigation of a novel diagnostic tool for concussion, in the form of a 3D head-mounted display and eye tracking system capable of assessing ocular, vestibular and reaction time (OVRT) functions (the I-PAS device, now re-named Dx 100).

The results of RESCUE-RACER will form an evidence base for medical decision-making track side after a potentially-concussive incident and will advise on clinic management of motorsports concussion, including the important 'return-to-race' decision.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Concussion, Brain Brain Concussion Brain Diseases Brain Injuries Brain Injuries, Traumatic Central Nervous System Diseases Craniocerebral Trauma Head Injuries, Closed Motor Vehicle Accident Nervous System Diseases Trauma, Nervous System Wounds and Injuries Wounds, Nonpenetrating

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mr Stephen Kelleher

Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(CArBON and CARS)

a) Competitive motorsports participants

Additional inclusion criteria - CARS only

  • Exposure to a potentially concussive event during motorsport activity OR a diagnosis of concussion during motorsport made by an experienced clinician <3 weeks prior to referral.
  • Mental capacity to consent to study participation

Exclusion criteria

(CArBON) Prior severe or moderate traumatic brain injury, diagnosis of mild traumatic brain injury or concussion within the last 6 months, symptoms of head injury at time of enrolment

Exclusion criteria

- (CArBON and CARS)

Absolute exclusion criteria

  • Age <16 years
  • Ongoing injuries so severe as to preclude study enrolment
  • Recent (within the last 4 months) or current involvement in a research study involving administration of trial medication

Possible exclusion criteria i. Recent (within the last 4 months) or current involvement in an observational research study (decision made by the enrolling study team member based upon the study's time commitments and the likelihood and feasibility of the participant attending future RESCUE-RACER assessments) ii. For MRI imaging only; metal implants or exposure to metal foreign objects (such as welding) - as per local policy (at the University of Cambridge Wolfson Brain Imaging Centre, WBIC).

Treatment and study plan

Clinical assessment (SCAT5)

Diagnostic Test

The SCAT5 is a standardized tool for evaluating sports-related concussions designed for use by physicians and licensed healthcare professionals in patients aged 13 years and above. It is a ten minute paper-based assessment which includes immediate and office/off-field assessments. SCAT5 incorporates the Maddocks' questions, Glasgow Coma Scale (GCS), cervical spine assessment and symptom evaluation, in addition to cognitive and neurological screening.

Other names: Sports Concussion Assessment Tool 5

ImPACT

Diagnostic Test

ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) is a neurocognitive assessment administered online or using desktop software in a controlled environment. ImPACT has two components: baseline testing and post-injury testing, both of which are used to determine if a patient can safely return to sporting activity post-concussion.

Other names: Immediate Post-concussion Assessment and Cognitive Testing, ImPACT concussion test

CANTAB

Behavioral

Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test Automated Battery (CANTAB) platform includes highly sensitive, precise and objective measures of cognitive function, correlated to neural networks. These tests have demonstrated sensitivity to detecting changes in neuropsychological performance and include tests of working memory, learning and executive function; visual, verbal and episodic memory; attention, information processing and reaction time; social and emotion recognition, decision making and response control.

The CANTAB touchscreen battery (www.camcog.com) will be utilised to perform neuropsychological assessments within RESCUE-RACER, whose study-specific protocol may include assessments of: Spatial Working Memory (working memory and strategy), Reaction Time (processing and psychomotor speed), Paired Associated Learning and the Multi-Tasking Test.

Other names: CANTAB Connect, Cambridge Cognition CANTAB battery, CANTAB battery

I-PAS/Dx100

Diagnostic Test

I-PAS™ (now re-named Dx 100) is a portable, head-mounted, neural functional assessment tool. With its integrated clinical eye tracking and digital display, the FDA has cleared (K171884) fourteen tests and an unmatched list of variables for clinical use for a variety of conditions. This utility of this device will be investigated for motorsport-related concussion.

Other names: OVRT, Ocular, vestibular and reaction time testing, I-Portal Portable Assessment System, Video Oculography, Dx100

Saliva sample

Biological

Micro RNA's (miRNA's) are easily measured in saliva and have proven to have both diagnostic and prognostic use in sports-related concussion across the adolescent and adult populations, with levels persisting for some weeks after the concussive event. RESCUE-RACER will collect saliva samples for analysis of biomarkers of concussion, which may include miRNA and other markers of injury.

fMRI

Other

RESCUE-RACER participants will be invited to complete a functional MRI scan, whose 90-minute protocol may include: multi-parametric mapping (MPM), susceptibility weighted imaging (SWI), diffusion weighted imaging (DWI), proton spectroscopy and functional MRI (fMRI) with blood oxygenation-level dependent contrast (BOLD), completed at 7T (Tesla), or 3T if this is not possible.

Other names: Magnetic Resonance Imaging, Function MRI

Primary outcomes

  1. Change in SCAT5 decision scores

    Time frame: Baseline (CArBON assessments) to 1-3 weeks after concussion (CARS assessments)

    Change in performance on the Sports Concussion Assessment Tool 5 (SCAT5) from baseline to follow-up, as measured by sections of the assessment:

    • Symptoms - number (range 0-22) and severity (each rated as 0-6), summed to form a symptom severity score (range 0-132), with higher scores indicating worse symptoms *For more information please see Step 2: Symptom Evaluation at link below*
    • Orientation score
    • Immediate memory score
    • Concentration score
    • Neurological examination
    • Number of balance errors
    • Delayed recall score

    Which are combined to form a Decision (please see Step 6 at https://bjsm.bmj.com/content/bjsports/early/2017/04/26/bjsports-2017-097506SCAT5.full.pdf).

  2. Change in computerised neurocognitive assessment scores

    Time frame: Baseline (CArBON assessment) to 1-3 weeks after concussion (CARS assessments)

    Change in neurocognitive performance from baseline to follow-up, as measured by the Immediate Post-concussion Assessment and Cognitive Testing tool (ImPACT, please see https://impacttest.com/).

    This previously-validated assessment consists of the following sections:

    • Attention (including processing)
    • Memory (verbal and visual recognition; visual working)
    • Visual motor speed
    • Learning
    • Impulse control (response inhibition)
    • Delayed memory (repeat of verbal and visual tasks in 2)

    Which are combined to form Composite scores, whose calculation is defined in the ImPACT's Administration & Interpretation Manual (available on request).

  3. Change in computerised neuropsychological assessment scores

    Time frame: Baseline (CArBON assessment) to 1-3 weeks after concussion (CARS assessments)

    Change in neuropsychological performance from baseline to follow-up, as measured by CANTAB Connect Research, the world's most validated, precise and reliable research software (please see http://www.cambridgecognition.com/products/cognitive-research/).

    This previously-validated assessment software consists of the following sections:

    • Attention (processing and psychomotor speed)
    • Memory (visual episodic)
    • Executive function and decision-making (working memory and strategy; planning).

    Each assessment produces a number of outputs, as detailed in the CANTAB Connect Research Overview Document (available on request).

  4. Change in the brain's microstructural architecture, or functional changes in the brain

    Time frame: Baseline (CArBON assessment) to 1-3 weeks after concussion (CARS assessments)

    Change in the brain's microstructural architecture, or functional changes in the brain, from baseline to follow-up as measured by:

    • High-resolution structural imaging - disruption of usual cerebral architecture (i.e. volume of sub/cortical structures)
    • Susceptibility-weighted imaging (SWI) - signal alteration
    • Diffusion-weighted imaging (DWI) - voxel intensity
    • Resting-state functional MRI (fMRI) - changes in blood oxygenation level
    • Proton spectroscopy

  5. Change in salivary biomarker levels

    Time frame: Baseline (CArBON assessments) to 1-3 weeks after concussion (CARS assessments)

    Change in the levels of salivary biomarkers from baseline to follow-up as potentially measured by markers of:

    • Neuronal injury - such as neurofilament light chain (NFL)
    • Glial injury - such as S100B (a calcium-binding peptide)
    • Epigenetic effects - as measured by micro RNA levels (miRNA)
    • Neurofibrillary degeneration - as measured by tau.

Secondary outcomes

  1. Altered performance in ocular, vestibular and reaction time (OVRT) assessment utilising the I-PAS/Dx100 device

    Time frame: Baseline (CArBON assessments) to 1-3 weeks after concussion (CARS assessments)

    The applicability of OVRT assessment as a diagnostic tool for motorsport concussion will be investigated by correlating changes in OVRT performance at baseline to OVRT performance following a clinical diagnosis of concussion or participation in motorsport activity. The assessment will be conducted with a portable head-mounted 3D display (please see http://neurolign.com/our-technology/, previously https://www.neuro-kinetics.com/products/).

    Alteration in OVRT performance will be measured using:

    • Ocular tests - saccades (vertical, horizontal, predictive, self-paced, memory-guided and anti-), smooth pursuit, optokinetic reflex, vergence, light reflex
    • Vestibular tests - subjective visual vertical
    • Reaction time assessments - auditory, visual

    The I-PAS/Dx100 training manual is available on request (publication of further assessment details is subject to patents and/or copyright).

Sponsors and collaborators

Lead sponsor

University of Cambridge

Other

Collaborators

  • Cambridge University Hospitals NHS Foundation Trust
  • Federation Internationale de l'Automobile - Year 2 onwards
  • Global Institute for Motorsport Safety (GIMSS) - Year 1
  • Neurolign Technologies LLC (previously Neuro Kinetics Incorporated, NKI)

Registry information

Acronym: RESCUE-RACER

Important dates

Study start
2018
Primary completion
2020
Study completion
2022
First posted
Feb 18, 2019
Registry last updated
Dec 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.